Please login to the form below

Not currently logged in
Email:
Password:

GSK’s Peter Harding appointed president of PAGB

Takes over from J&J’s Alex Pitt to lead UK consumer healthcare trade body

PAGB Peter HardingThe Proprietary Association of Great Britain (PAGB) has appointed GlaxoSmithKline's (GSK) general manager of UK consumer healthcare Peter Harding as its new president.

Harding (pictured right) was previously VP of the PAGB, which represents manufacturers of over-the-counter (OTC) medicines and food supplements, and takes over from outgoing president Alex Pitt who has recently moved to a new role in Switzerland with Johnson & Johnson (J&J).

“I am delighted that Peter has been willing to take on the role of PAGB president and I look forward to working with him to deliver the programmes that will help stimulate the development of the OTC market in the UK,” said PAGB's chief executive Sheila Kelly.

Harding joined GSK in 1997 and has previously served as general manager of its nutritional healthcare in the UK, working with GSK products including Ribena and Lucozade, before the nutritional business was merged with consumer healthcare.

“I'm very pleased to be taking up this role at a time when our industry continues to be faced with a lot of change,” said Harding.

“I'm very excited by the work programmes that we've put in place in 2012 and genuinely believe that these initiatives will contribute positively to driving innovation in our sector and growth in the market.“

20th September 2012

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics